Clinician's Brief: The Podcast

Ear cytology gives us information that a visual examination—or even sniff test—simply cannot, yet we too often forgo this essential diagnostic step. In this episode of the Partner Podcast, Dr. Beth talks with Liz Layne, DVM, DACVD, and Christi Belew, DVM, about the role of cytology in otitis externa management. They share practical tips for interpreting samples and explore how emerging analyzer technology is bringing a new level of consistency and accuracy to in-clinic results.

Sponsored by IDEXX

Resource: 

https://www.idexx.com/en/veterinary/analyzers/invue-dx-analyzer/test-types/ear-cytology/

Contact us:

Podcast@instinct.vet

Where to find us:

Website: CliniciansBrief.com/Podcasts

YouTube: Youtube.com/@clinicians_brief

Facebook: Facebook.com/CliniciansBrief

LinkedIn: LinkedIn.com/showcase/CliniciansBrief/

X: @cliniciansbrief

Instagram: @clinicians.brief

The Team:

Beth Molleson, DVM - Host

Taylor Argo- Producer, Sound Editing, & Project Manager, Brief Studio

Welcome to the Veterinary Breakroom! Join Alyssa Watson, DVM, and Beth Molleson, DVM, as they discuss pressing issues impacting the veterinary profession. Corporate consolidators are offering associates equity in veterinary practices at an increasing rate, and the pitch can sound pretty compelling. But, is a minority stake actually the partnership it's made out to be? Tune in as Dr. Alyssa and Dr. Beth react to a recent VIN News Service article on the trend, consider what the fine print can mean for career mobility, and reflect on the gap between feeling like an owner and actually being one.

Brought to you by Zoetis

Resources:

https://news.vin.com/default.aspx?pid=210&Id=13200511

https://www.apoquel.com

Contact:

podcast@instinct.vet

Where To Find Us:

Website: CliniciansBrief.com/Podcasts

YouTube: Youtube.com/@clinicians_brief

Facebook: Facebook.com/CliniciansBrief

LinkedIn: LinkedIn.com/showcase/CliniciansBrief/

Instagram: @Clinicians.Brief

X: @CliniciansBrief

The Team:

Alyssa Watson, DVM - Host

Beth Molleson, DVM - Host

Alexis Ussery - Producer & Multimedia Specialist

Disclaimer: This podcast recording represents the opinions of Dr. Alyssa Watson and Dr. Beth Molleson. Content is presented for discussion purposes and should not be taken as medical advice. No guarantee is given regarding the accuracy of any statements or opinions made on the podcast.

In this episode, host Alyssa Watson, DVM, is joined by Linda E. Luther, DVM, MVSc, DACVIM (SAIM), to discuss her recent Clinician’s Brief article, “Manipulation of the Renin-Angiotensin-Aldosterone System.” Dr. Luther delves into proteinuria, hypertension, heart disease, and the often overlooked hyperaldosteronism as conditions that feature chronic RAAS activation. She explains how each of our therapeutic options—ACE inhibitors, angiotensin II receptor blockers (ARB), spironolactone—are best put to use.

Resources:

https://www.cliniciansbrief.com/article/raas-suppression-dogs-cats

https://www.zoetisus.com/petcare/care-is-your-calling/

Contact:

podcast@instinct.vet

Where To Find Us:

Website: CliniciansBrief.com/Podcasts

YouTube: Youtube.com/@clinicians_brief

Facebook: Facebook.com/CliniciansBrief

LinkedIn: LinkedIn.com/showcase/CliniciansBrief/

Instagram: @Clinicians.Brief

X: @CliniciansBrief

The Team:

Alyssa Watson, DVM - Host

Alexis Ussery - Producer & Multimedia Specialist

Welcome to the Veterinary Breakroom! Join Alyssa Watson, DVM, and Beth Molleson, DVM, as they discuss pressing issues impacting the veterinary profession. New World Screwworm is back in the headlines, and it may be closer to home than you realize. In this episode, we sit down with special guest Dr. Jim Budde, Chief Pharmacy Officer at Instinct, to break down what clinicians need to know about this flesh-eating parasite, which drugs are being used to protect pets, and how to counsel clients who are asking questions.

Brought to you by Zoetis

Resources:

https://www.wormsandgermsblog.com/

https://www.cliniciansbrief.com/article/new-world-screwworm-veterinary-guide

https://www.avma.org/resources-tools/one-health/veterinarians-and-public-health/new-world-screwworm

https://www.aphis.usda.gov/animals/animal-health/livestock-and-poultry-disease/stop-screwworm

https://www.fda.gov/animal-veterinary/safety-health/new-world-screwworm-information-veterinarians#Approval

https://www.aphis.usda.gov/animals/animal-health/livestock-and-poultry-disease/current-status/us-confirmed-cases-new-world

https://www.apoquel.com

Contact:

podcast@instinct.vet

Where To Find Us:

Website: CliniciansBrief.com/Podcasts

YouTube: Youtube.com/@clinicians_brief

Facebook: Facebook.com/CliniciansBrief

LinkedIn: LinkedIn.com/showcase/CliniciansBrief/

Instagram: @Clinicians.Brief

X: @CliniciansBrief

The Team:

Alyssa Watson, DVM - Host

Beth Molleson, DVM - Host

Alexis Ussery - Producer & Multimedia Specialist

Disclaimer: This podcast recording represents the opinions of Dr. Alyssa Watson and Dr. Beth Molleson. Content is presented for discussion purposes and should not be taken as medical advice. No guarantee is given regarding the accuracy of any statements or opinions made on the podcast.

As our understanding of canine osteoarthritis deepens and treatment options continue to expand, there's never been a better opportunity to refine how we approach this disease in practice. In this episode of the Partner Podcast, Dr. Beth invites Dr. Monica Tarantino to explore what's actually happening in the arthritic joint, why inflammation deserves its own place in the treatment conversation, and how she navigates anti-inflammatory options in her senior patients.

Sponsored by Elanco

Indication

Galliprant controls pain and inflammation associated with osteoarthritis in dogs.

Important Safety Information

For use in dogs only. Keep this and all medications out of reach of children and pets to prevent accidental ingestion or overdose. Galliprant is a non-COX inhibiting NSAID. As a class, NSAIDs may be associated with gastrointestinal, kidney and liver side effects. Evaluation for pre-existing conditions and regular monitoring are recommended. Do not use in dogs that have a hypersensitivity to grapiprant. Concomitant use of Galliprant with other NSAIDs or corticosteroids should be avoided. Concurrent use with other anti-inflammatory drugs or protein-bound drugs has not been studied. The safe use of Galliprant has not been evaluated in dogs younger than 9 months of age and less than 8 lbs (3.6 kg), dogs used for breeding, pregnant or lactating dogs, or dogs with cardiac disease. Owners should be advised to observe for signs of potential drug toxicity. Adverse reactions may include vomiting, diarrhea, decreased appetite, watery or bloody stools, and decreases in serum albumin and total protein. Click here for full prescribing information. 

Contact us:

Podcast@instinct.vet

Where to find us:

Website: CliniciansBrief.com/Podcasts

YouTube: Youtube.com/@clinicians_brief

Facebook: Facebook.com/CliniciansBrief

LinkedIn: LinkedIn.com/showcase/CliniciansBrief/

X: @cliniciansbrief

Instagram: @clinicians.brief

The Team:

Beth Molleson, DVM - Host

Sarah Pate - Producer & Project Manager, Brief Studio

Taylor Argo- Podcast Production & Sound Editing